NanoViricides Inc. (NNVC)

[robi-1-kenobi]

Maybe weak hands think "all or nothing", but the strong hands understand the significance of FluCide efficacy with 100% survival of otherwise lethal Flu exposures and orders of magnitude reduction in viral load over existing drugs (Tamiflu, etc).

I don't deny that the shareprice will likely decline if EbolaCide2 doesn't move forward. There is a 12-18mo preclinical timeline stated now for their lead program of FluCide and a management team that has always mis-estimated timelines.

But they have enough money to get to IND/CTx before I think they will want to raise money again and enough capital to put FluCide through Phase I/IIa if they pushed it to empty.

Successful preclinical work for FluCide and IND/CTx approval will see them through. If they are unsuccessful with FluCide preclinical testing (either safety or broad spectrum efficacy or completion of testing before next needed capital raise) then I might have to agree with you.